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Abstract: A concise synthesis of stereodefined C-substituted morpholines, piperazines, azepines and oxazepines in moderate to 
excellent yields (27% to 75%) is reported by reaction of 1,2- or 1,3-amino alcohol/1,2- or 1,3-diamine with an α-
phenylvinylsulfonium salt. High levels of regio- and diastereoselectivity (from 2:1 to >20:1) are observed through judicious choice 
of base (Cs2CO3), and solvent (CH2Cl2). Reactions are performed at ambient temperature and open to air and do not require 
anhydrous solvent. The deprotection of the N-sulfonamide protecting groups (N-Ts and N-Ns) is also demonstrated. Factors 
affecting regio- and diastereocontrol are discussed.  
The question “are we making the right molecules?” has 
hung over the pharmaceutical industry for many years.
1
 
Njardarson analyzed all U.S. FDA approved small molecule 
drugs
2
 and found that 21% (71)
3
 contained saturated 6-
membered N-heterocycles with an additional heteroatom. 
Clearly, morpholines and piperazines are in “the right 
molecules” category and this demand continues to stimulate 
new methods for their synthesis. Current state of the art 
methods for the synthesis of saturated N-heterocycles 
containing an additional heteroatom include Ti-mediated 
hydroamination/reduction,
4
 Pd-mediated carboamination,
5
 
photoredox C-H arylation,
6
 nucleophilic substitution,
7
 Lewis 
acid catalyzed ring expansion of 3-oxetanone spirocycles,
8
 
ammonium persulfate mediated SN2-type ring opening of 
aziridines with halogenated alcohols
9
 and the SnAP reagents 
developed by Bode.
10
 The latter method is the most attractive 
in terms of generality, substitution patterns and lack of 
protecting groups that it can accommodate. However, the use 
of toxic tin reagents unfortunately detracts from the 
chemistry and its applicability in an industrial setting. Herein 
we report a new complementary method for the synthesis of 
di- and trisubstituted saturated N-heterocycles bearing a 
second heteroatom with very high regio- and diastereo-
control, using our recently developed α-arylvinylsulfonium 
salt.
11 
We have previously investigated the synthesis of saturated 
N-heterocycles bearing an additional heteroatom using 
vinylsulfonium salt 2 (Scheme 1).
7,12
 This methodology has 
proven to be versatile for the construction of N-heterocycles 
bearing an ethylene bridge.
13
 In order to access more 
substituted N-heterocycles we considered the use of 
vinylsulfonium salts, with either α- or β-substituents (5 and 
6) (Scheme 1). However, for a successful process, the 
challenges of controlling both regioselectivity during the 
initial conjugate addition (attack through O vs. N), and  
Scheme 1. Synthesis of saturated N,X-heterocycles using 
vinylsulfonium salts. 
 
diastereoselectivity would need to be overcome. In this paper 
we describe our success in achieving these goals. 
Table 1. Synthesis of substituted morpholines with 10.  
 
entry substrate R1 R2 R3 11 
(%)a 
12 
(%)a 
drb 
1 9a Me Me H 67 13 - 
2 9b (R)-
Me 
H (S)-
Ph 
53 21 1.1:1 
3 9c (S)-Bn H H 59 8 1.5:1 
(a) Isolated yields. (b) Diastereoselectivity was determined from 1H 
NMR of the crude reaction mixtures.  
Initially, we investigated the annulation of 1,2-amino-
alcohols 9a-c with the known β-phenylvinylsulfonium salt 
10.
14
 Treatment of 9a-c with DBU as a base, gave 
morpholines 11a-c in good yields and with complete 
regioselectivity (conjugate addition through O rather than N) 
(Table 1, entries 1-3). Although the initial results were 
promising these reactions suffered from several problems 
highlighting some of the challenges faced. Incomplete 
conversion was observed for all substrates, and a competing 
side reaction involving elimination of the intermediate 
sulfonium salt was also observed, leading to the isolation of 
side-products 12a-c. Furthermore, both morpholines 11b and 
11c were formed as ~1:1 mixtures of diastereomers. 
We then investigated α-phenylvinylsulfonium salt 13.
11
 
Initial reaction screening focused on the (R)-alanine-derived 
N-tosyl protected amino alcohol 14. Treatment of 14 with 
13, in the presence of DBU as the base (Table 2, entry 1) led 
to the formation of the desired compound 15, albeit in poor 
yield as a mixture of isomers. An improvement in yield was 
achieved through batch-wise addition of 13 (Table 2, entry 
2). Preparative HPLC separation and analysis of the two 
major isomers by 
13
C/HSQC NMR indicated that a 2:1 
mixture of regioisomers had been formed. The relative 
stereochemistry of the major regioisomer was confirmed by 
X-ray crystallography (cis-15a) and the relative 
stereochemistry of the minor regioisomer was determined to 
be cis-15b through analysis of 
3
JHH coupling constants. 
These initial results also confirmed that excellent levels of 
diastereoselectivity were observed. Further optimization of 
the reaction conditions eventually revealed Cs2CO3/CH2Cl2 
as the base and solvent of choice for this reaction. 
Pleasingly, this base and solvent system led to complete 
regioselectivity, with conjugate addition occurring through 
O, generating almost exclusively cis-15a (Table 2, entries 3-
6, see SI for full optimisation table). Batch-wise addition of 
both Cs2CO3 and 13 was necessary to ensure that the 
reaction went to completion, due to competing 
decomposition of 13 under the reaction conditions over time. 
The operational simplicity of the reaction should also be 
noted, allowing the chemistry to be performed over short 
reaction times, open to air and on a gram scale (Table 2, 
entry 6).  
Table 2. Optimization of reaction conditions with 13. 
 
entry base 
(equiv.) 
13 
(equiv.) 
time 
(h) 
temp 
(°C) 
15 
(%)a 
isomeric 
ratiob 
15a:15b 
1 DBU 
(3.5) 
1.2 24 rt 9 2:1 
2 DBU 
(3.5) 
2 × 1 24 0 
then 
rt 
45 2:1 
3 Cs2CO3 
(3.5) 
1.2 24 rt 18 20:1 
4 Cs2CO3 
(3.5) 
3 24 rt 64 20:1 
5 Cs2CO3 
(2 × 2) 
3 6 rt 71 20:1 
6 Cs2CO3 
(2 × 2) 
2 × 1 6 rt 76 
(73)c,d 
20:1 
(a) 1H NMR yields of 15 calculated from the crude reaction mixture 
using 1,3,5-trimethyoxybenzene as the internal standard. (b) Isomeric 
ratio represents the ratio of the two major isomers formed during the 
reaction (15a and 15b). (c) Isolated yield in parentheses. (d) Identical 
reaction performed on gram scale open to air using bench CH2Cl2 as the 
solvent gave 77% (72%) of 15. (See SI for full optimisation table). 
With an optimized procedure in hand, the substrate scope 
of the reaction was then investigated (Scheme 3). Amino-
alcohols derived from enantiopure amino acids valine 16a, 
phenylalanine 16b, tryptophan 16c and serine 16d all 
underwent the desired transformation to give morpholines 
17a-d in excellent yields and with excellent 
regio/diastereoselectivity. Furthermore, 16a-c could be 
isolated as single isomers by recrystallization, albeit in 
slightly reduced yields. In contrast to substrates 17a-d, the 
tert-butyl ester morpholine 17e was formed as a 2:1 mixture 
of regioisomers, which we were unable to separate. More 
hindered substrates 16f and 16g also participated in the 
reaction to give the desired morpholines 17f and 17g in good 
yields, with excellent regioselectivities. Unfortunately, under 
these optimized conditions substrates bearing the following 
protecting groups - Boc, Cbz, Troc, Bn, COCF3, or 
unprotected nitrogen, failed, giving either unreacted starting 
material or polar compounds which could not be identified. 
However, the related nosyl
15
 protected amino-alcohol 16h 
was compatible, giving morpholine 17h in slightly lower 
yield and with lower regioselectivity in comparison to the  
Scheme 3. Substrate scope. 
(a) Isolated yield after column chromatography. (b) Ratio of 
regioisomers determined from the 1H NMR of the crude reaction 
mixtures prior to purification. (c) Isolated yield after recrystallization to 
obtain a single regioisomer. (d) trans-17e was formed as a 1:1 mixture 
of diastereomers (see SI). The yield reported is the isolated yield after 
recrystallization which lead to an enrichment of the trans-17e 
diastereomer. (e) cis-17i was formed as a 6:1:1:1 mixture of 
regioisomers and diastereomers. (f) cis-17k was formed as a 3:1 mixture 
of diastereomers. (g) NOE and 3JHH analysis was used to confirm the 
relative stereochemistry of cis-17m. (h) cis-17n was formed as a 2:1 
mixture of diastereomers as determined by analysis of 3JHH coupling 
constants (see SI). 
tosyl protected amino-alcohol 14. 
The methodology is also applicable to substrates 16i-k 
with substituents α to oxygen and/or nitrogen leading to the 
formation of di- and tri-substituted morpholines 17i-k in 
good yields and with moderate selectivities. For substrate 
17k, excellent regioselectivity was achieved, but lower 
diastereoselectivity was observed. The synthesis of C-
substituted piperazines was also possible starting from 1,2-
diamine substrates 16l-n. The corresponding piperazines 17l-
n were formed in good yields and with good diastereo- (17l) 
and regioselectivities (17m) for some substrates, but low 
diastereoselectivities for others (17n). Finally, the 
application of α-phenylvinylsulfonium salt 13 to the 
synthesis of substituted azepines and oxazepines was also 
conducted and the 7-membered heterocycles 17o and 17p 
were formed in moderate yields but very high 
regioselectivity.  
Scheme 2. Rationale for the observed regio- and 
diastereoselectivity. 
 
A rationale for the observed regio- and 
diastereoselectivities is proposed (Scheme 2). The observed 
regioselectivity results from a faster rate of reaction of the 
more nucleophilic oxygen nucleophile, despite its lower 
concentration [TsNH (pKa 17 DMSO
16
) vs. OH (pKa 30 
DMSO
17
)]. The diastereoselectivity of this transformation is 
set during the SN2 displacement, which proceeds through 
two diastereomeric transition states A and B. The major 
diastereomer results from placing all substituents in pseudo-
equatorial positions (A) whilst the minor diastereomer 
results from placing the phenyl group in a pseudo-axial 
position (B). The cyclized product C then ring flips because 
of unfavourable gauche interactions to give the major isomer 
cis-15a. Although cis-15a has an unfavourable 1,3-diaxial 
interaction, this conformation is observed in solution [
3
JHH 
PhCH (d, J 4.0 Hz)]. Conformer C would be expected to 
have one large 
3
JHH (ax-ax) and one small coupling 
3
JHH (ax-
eq) which are not observed. We have observed similar 
effects in thiomorpholines previously.
18
 
To demonstrate synthetic utility, N-Ts morpholine cis-15a 
was deprotected using a sodium/naphthalene reduction, and 
isolated as the hydrochloride salt 18 in excellent yield, as a 
single diastereoisomer. The SNAr deprotection of N-Ns 
morpholine cis-17h with 2-mercaptoethanol and DBU
19
 was 
also achieved leading to the HCl salt 18 in excellent yield. 
As signals overlapped in the 
1
H NMR of 18, it was Boc 
protected to give 19 which allowed the coupling constants to 
be measured; these showed a good correlation with the 
parent N-sulfonamides cis-15a and cis-17h.     
Scheme 3. Deprotection of morpholines.  
 
Conditions A: Na/naphthalene (3 equiv.), DME (0.1 M), ‒78 °C, 30 min. 
(B) 2-mercaptoethanol (2 equiv.), DBU (2 equiv.), acetone (0.2 M), rt, 
30 min. (C) HCl (1 M in Et2O, 1.5 equiv.), rt, 5 min. 
In conclusion, we have developed a highly practical route 
to stereodefined C-substituted morpholines, piperazines, 
azepines and oxazepines in moderate to excellent yields, 
using our recently developed α-phenylvinylsulfonium salt 
13. The method exhibits high levels of regio- and 
diastereoselectivity and is operationally simple. Reactions 
are conducted open to air, with non-anhydrous solvents, on 
gram-scale using readily available starting materials and 
reagents. The methodology enables rapid construction of 
spatially-defined substituents and heteroatoms in small 
molecules from flexible acyclic precursors – features which 
will resonate with drug discovery programs. 
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